Bioray Laboratories
Clinical trials sponsored by Bioray Laboratories, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- One-Shot gene fix for blood disorder enters human testing Results expected Oct 2026 (estimated)
- New CAR-T therapy targets Hard-to-Treat lymphoma Results expected Nov 2026 (estimated)
- New CAR t therapy targets Hard-to-Treat blood cancer Results expected Mar 2027 (estimated)
- Off-the-Shelf cell therapy takes on tough lymphoma Results expected Aug 2027 (estimated)